Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN EBITDA Margin
EBITDA as a percentage of revenue.
Orion Group Holdings, Inc.NYSE: ORN
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to 2.4%
EBITDA Margin was 2.4% in Q1 FY2026, down 0.7 pp from a year earlier. On a trailing-twelve-month basis it was 4.3%, up 0.1 pp year over year. Over 3 fiscal years it widened by 3.5 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 5.6% for the fiscal year ending Dec 2026, up from 5.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 2.4%-2.4 pp QoQ
- Last fiscal yearDec 2025
- 5.0%+1.0 pp YoY
- LTMMar 2026
- 4.3%+0.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.7 pp | +2.3 pp | +3.0 pp |
| 1 year | +1.0 pp | +0.6 pp | -0.4 pp |
| 3 years | +3.5 pp | +1.5 pp | -2.0 pp |
| 5 years | +2.9 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 5.0%
- Year-over-year change
- +1.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.0% | +1.0pp |
| FY2024 | 2024-12-31 | 3.9% | +1.7pp |
| FY2023 | 2023-12-31 | 2.2% | +0.7pp |
| FY2022 | 2022-12-31 | 1.5% | +0.7pp |
| FY2021 | 2021-12-31 | 0.8% | — |
EBITDA Margin vs competitors
How ORN compares with its peers on the latest reported figures
- ORN's LTM Mar 2026 EBITDA Margin of 4.3% is the 6th highest of the 10 companies compared; the peer median is 5.3%.
- Its year-over-year change of +0.1 pp is the 5th highest of 10, against a peer median of -0.2 pp.
- Over three fiscal years its change of +3.5 pp compares with a peer median of +0.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Apr 2026 | 24.3% | -1.3 pp | -6.1 pp | |
| LTM Mar 2026 | 23.1% | +5.1 pp | +0.5 pp | |
| LTM Feb 2026 | 19.3% | +1.9 pp | +1.3 pp | |
| LTM Feb 2026 | 10.8% | -0.2 pp | +25.9 pp | |
| LTM Apr 2026 | 5.3% | -11.4 pp | -10.4 pp | |
| LTM Mar 2026 | 4.3% | +0.1 pp | +3.5 pp | |
| LTM Apr 2026 | -0.4% | -12.1 pp | -17.3 pp | |
| LTM Mar 2026 | -0.5% | +1.0 pp | +3.3 pp | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | -2.7% | +5.5 pp | +8.6 pp |
| LTM Mar 2026 | -77.4% | -542.7 pp | -1.4 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding ORN) | 5.3% | -0.2 pp | +0.5 pp | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 601.36M | 748.32M | 711.78M | 796.39M | 852.26M |
| Cost of Revenue | 560.39M | 697.58M | 650.12M | 705.23M | 746.65M |
| Gross Profit | 40.97M | 50.74M | 61.66M | 91.16M | 105.61M |
| Gross Margin | 6.8% | 6.8% | 8.7% | 11.4% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.18M | 62.5M | 69.43M | 82.54M | 93.47M |
| Operating Expenses | 50.28M | 58.77M | 68.29M | 79.64M | 93.47M |
| Depreciation & Amortization | 25.43M | 24.06M | 23.88M | 22.77M | 30.52M |
| EBITDA | 4.7M | 11.06M | 15.68M | 31.39M | 42.29M |
| EBITDA Margin | 0.8% | 1.5% | 2.2% | 3.9% | 5.0% |
| Operating Income | (9.32M) | (8.03M) | (6.63M) | 11.52M | 12.14M |
| Operating Margin | -1.5% | -1.1% | -0.9% | 1.4% | 1.4% |
| Interest Income | 136K | 104K | 103K | 207K | 0 |
| Interest Expense | 5.08M | 4.46M | 11.66M | 13.38M | 8.56M |
| Other Income / Expenses | (4.74M) | (4.15M) | (10.92M) | (12.82M) | (9.24M) |
| Income Before Tax | (14.06M) | (12.18M) | (17.55M) | (1.3M) | 2.91M |
| Pre-Tax Margin | -2.3% | -1.6% | -2.5% | -0.2% | 0.3% |
| Income Tax Expense | 502K | 429K | 330K | 348K | 419K |
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Net Margin | -2.4% | -1.7% | -2.5% | -0.2% | 0.3% |
| EPS (Basic) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| EPS (Diluted) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| Weighted Avg Shares | 30.76M | 31.4M | 32.35M | 34.78M | 39.63M |
| Weighted Avg Shares (Diluted) | 30.76M | 31.4M | 32.35M | 34.78M | 39.64M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.